BioHealth News Archive
Four Tips For Raising Venture Capital In The Biotechnology Sector
In a world where it seems like startups are created every other day and market economics remain largely unpredictable, securing funding for your biotech…
Read MoreDraft ROI Report is a Promising Roadmap for Accelerating Tech Transfer
After months of anticipation, the just released draft paper Return on Investment Initiative to Advance the President’s Management Agenda: Unleashing American Innovation signals that the…
Read MoreCamden Partners Nexus co-leads $3.7M investment in pharmaceutical company treating hearing loss – Technical.ly Baltimore
Early-stage pharmaceutical company Spiral Therapeutics received $3.7 million in new investment as it looks to advance treatments for hearing loss and other inner ear…
Read MoreFrederick National Laboratory, Frederick Innovative Technology Center Inc. partner for accelerator – fredericknewspost.com
The Frederick National Laboratory for Cancer Research and the Frederick Innovative Technology Center Inc. signed a memorandum of understanding with partners Monday to start…
Read MoreThe Gene Therapy Market is going to produce a Microsoft – American Gene Technology
The most common analogy used to compare the science of DNA to other industries is that of computer software. DNA can be viewed as…
Read More2018 In Review with MIMETAS’ CEOs
2018 was a year in which we saw explosive growth at Mimetas. After such a hectic and promising year, it is important to take…
Read MoreJLABS: This Incubator Knows How to Get Biotech Companies Started
When it comes to drug discovery and development, nowadays a lot of the work is done by small- or medium-sized healthcare companies. The biopharma…
Read MoreWhy do digital health startups keep failing?
A decade ago, a wave of companies promised to transform people’s health by allowing them to track data about their eating, sleep, exercise, and…
Read MoreCELLINK and Prellis Biologics announce powerful, $1.2M Holograph-X Bioprinter – 3D Printing Media Network
Swedish bioprinting company CELLINK has entered into a partnership with organ and tissue engineering company Prellis Biologics, Inc. with the goal of commercializing high-resolution…
Read MoreQIAGEN announces new collaboration to develop companion diagnostic to guide treatment for patients with PIK3CA-mutated advanced breast cancer | Business Wire
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that a clinical development program is underway with Novartis to bring to market a…
Read MoreApplying Deep Learning to PD-L1 Expression
Perhaps the greatest promise of Artificial Intelligence (AI) is its potential to enhance our ability to predict, diagnose, and treat disease. That is why…
Read MoreFDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial – Inova Newsroom
In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or…
Read MoreGSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics
GlaxoSmithKline announced this morning that it will buy Tesaro, the maker of the ovarian cancer drug Zejula, for $5.1 billion in cash in a…
Read MoreCommerce’s NIST Announces Actions to Stimulate Commercialization of Federally Funded R&D | NIST
The United States spends more than any other nation on research and development (R&D) each year, investing over $150 billion in federally funded R&D…
Read MoreGreater Washington Board of Trade releases 2019-2021 Strategic Plan
The Board of Trade has served Greater Washington and its business community for 130 years. Today, it released a new three-year strategy for driving…
Read More